Nektar Therapeutics (NKTR) Business Metric Overview - Stocknear

Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
38.13
2.15 (5.98%)
At close: Sep 05, 2025, 1:05 PM

Nektar Therapeutics Revenue Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018
Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue 11.18M 10.46M 33.03M 15.73M 16.79M 15.51M 18.06M 18.17M 15.83M 16.86M 17.63M 18.34M 16.26M 17.56M 19.08M 19.41M 20.46M 18.8M 20.56M 10.42M 7.68M 9.89M 8.72M 10.26M 9.09M 8.23M 8.97M 8.37M 9.04M
Non Cash Royalty Revenue Related To Sale Of Future Royalties Revenue Growth +6.84% -68.33% +109.95% -6.31% +8.27% -14.14% -0.58% +14.75% -6.10% -4.35% -3.90% +12.78% -7.39% -7.96% -1.72% -5.10% +8.82% -8.58% +97.29% +35.63% -22.34% +13.50% -15.06% +12.90% +10.46% -8.26% +7.15% -7.44% n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 17.07M 24.35M 17.14M 18.96M 20.51M 20.15M 17.32M 21.15M 17.87M 21.08M 21.94M 22.53M 20.52M 27.34M 32.14M 29.47M 29.55M 31.68M 27.14M 26.98M 24.35M 26.22M 27.14M 23.98M 22.58M 25.01M 23.78M 18.72M 20.26M 18.69M 12.34M 12.05M 16M 11.98M 12.76M 10.25M 11.04M 10.23M 13.23M 9.54M 10.18M 10.3M
Selling, General, and Administrative Revenue Growth -29.88% +42.08% -9.61% -7.57% +1.79% +16.33% -18.10% +18.34% -15.24% -3.91% -2.64% +9.81% -24.94% -14.94% +9.07% -0.29% -6.70% +16.74% +0.57% +10.82% -7.13% -3.41% +13.17% +6.21% -9.70% +5.17% +27.03% -7.62% +8.42% +51.47% +2.34% -24.64% +33.57% -6.14% +24.45% -7.09% +7.89% -22.72% +38.67% -6.28% -1.16% n/a
Research and Development Revenue 29.89M 30.48M 28.75M 35.03M 29.72M 27.41M 29.94M 24.07M 29.68M 30.47M 34.74M 33.59M 42.74M 107.25M 99.61M 103.74M 101.31M 95.6M 102.72M 100.53M 96.44M 108.99M 110.37M 99.05M 106.69M 118.46M 108.88M 102.89M 88.33M 99.42M 81.43M 65.71M 60.26M 61.06M 50.23M 51.95M 52.35M 49.27M 47.13M 43.23M 45.41M 47.01M
Research and Development Revenue Growth -1.95% +6.04% -17.94% +17.85% +8.45% -8.46% +24.40% -18.90% -2.59% -12.29% +3.42% -21.41% -60.15% +7.67% -3.98% +2.39% +5.97% -6.93% +2.18% +4.25% -11.52% -1.25% +11.43% -7.16% -9.94% +8.80% +5.82% +16.48% -11.15% +22.10% +23.91% +9.05% -1.31% +21.55% -3.31% -0.76% +6.26% +4.53% +9.04% -4.81% -3.40% n/a